[2] However, the subsequent analysis found that the application of clopidogrel and aspirin compared with aspirin alone reduced the risk of recurrent stroke only in patients who were non-carriers of the CYP2C19 loss-of-function (LOF) alleles. This evidence concerns the gene CYP2C19 and Stroke.